PTC Therapeutics, Inc. (PTCT)
71.06
+1.24
(+1.78%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
-0.04
(-0.06%)
After-Hours: 20:00
PTC Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2022 | 1838.93 |
| March 29, 2022 | 1915.78 |
| March 28, 2022 | 1784.25 |
| March 25, 2022 | 1822.68 |
| March 24, 2022 | 1844.35 |
| March 23, 2022 | 1814.79 |
| March 22, 2022 | 1859.13 |
| March 21, 2022 | 1802.97 |
| March 18, 2022 | 1862.09 |
| March 17, 2022 | 1807.90 |
| March 16, 2022 | 1755.68 |
| March 15, 2022 | 1685.73 |
| March 14, 2022 | 1667.50 |
| March 11, 2022 | 1687.70 |
| March 10, 2022 | 1737.95 |
| March 09, 2022 | 1739.42 |
| March 08, 2022 | 1652.23 |
| March 07, 2022 | 1664.55 |
| March 04, 2022 | 1641.89 |
| March 03, 2022 | 1676.86 |
| March 02, 2022 | 1683.76 |
| March 01, 2022 | 1690.16 |
| February 28, 2022 | 1730.06 |
| February 25, 2022 | 1757.16 |
| February 24, 2022 | 1774.89 |
| Date | Value |
|---|---|
| February 23, 2022 | 1755.19 |
| February 22, 2022 | 1894.11 |
| February 18, 2022 | 1924.15 |
| February 17, 2022 | 1927.11 |
| February 16, 2022 | 2005.93 |
| February 15, 2022 | 2030.07 |
| February 14, 2022 | 2026.13 |
| February 11, 2022 | 2101.99 |
| February 10, 2022 | 2162.58 |
| February 09, 2022 | 2197.06 |
| February 08, 2022 | 2150.76 |
| February 07, 2022 | 2126.62 |
| February 04, 2022 | 2073.42 |
| February 03, 2022 | 1968.49 |
| February 02, 2022 | 1940.90 |
| February 01, 2022 | 1996.57 |
| January 31, 2022 | 1981.30 |
| January 28, 2022 | 1922.68 |
| January 27, 2022 | 1897.55 |
| January 26, 2022 | 1959.62 |
| January 25, 2022 | 1928.59 |
| January 24, 2022 | 1976.37 |
| January 21, 2022 | 1912.33 |
| January 20, 2022 | 1973.91 |
| January 19, 2022 | 2026.62 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed, Inc. | 35.73 |
| Madrigal Pharmaceuticals, Inc. | 22.58 |
| Protagonist Therapeutics, Inc. | 11.89 |
| Biogen, Inc. | 1.709 |
| BioMarin Pharmaceutical, Inc. | 1.992 |
Price to Book Value Related Metrics
| PS Ratio | 6.029 |
| Price | 71.06 |
| Earnings Yield | -0.84% |
| Market Cap | 5.921B |
| Operating PE Ratio | 52.10 |